Breaking News
Sort by:
Top Post
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]
Samsara Therapeutics Establishes Scientific Advisory Board
Samsara Therapeutics Inc. (Samsara), a discovery-stage biotech with a world-leading screening platform for inducers of […]
Univercells Acquires SynHelix, Entering into Synthetic Biology and the Race to Next-generation DNA Synthesis
Univercells S.A. (Univercells) today announces its acquisition of SynHelix, a biotechnology company that aims to debottleneck […]
SomaLogic Announces Exclusive Partnership with Illumina to Develop Sequencing-based Proteomic Solutions
SomaLogic (NASDAQ: SLGC), a leader in data-driven proteomics technology, today announced a worldwide strategic collaboration […]
Anthos Therapeutics Appoints David McIntyre as Chief Financial Officer
Anthos Therapeutics, a late-stage biotechnology company developing innovative therapies for cardiovascular and metabolic diseases, today […]
PhoreMost and POLARISqb Announce a Multi-target Collaboration to Investigate Next-generation Cancer Therapies
PhoreMost Limited, a UK-based biopharmaceutical company dedicated to developing drugs against intractable disease targets, and […]
PRISM BioLab Enters Multi-Project Drug Discovery Collaboration with Roche and Genentech
PRISM BioLab, a Japan based biotechnology company with a proprietary peptide mimetic small molecule drug discovery […]
Leiden Medical Center and Intravacc to Start Clinical Trial with New Intranasal Corona Vaccine
Intravacc, a global leader in translational research and development of therapeutic vaccines and vaccines against […]
Babylon Acquires Higi to Extend its Digital-First Healthcare Platform to Millions of People in the U.S.
Babylon today announced the closing on December 31, 2021 of its acquisition of Higi SH […]
Alamar Biosciences Partners with Abcam to Drive Understanding of the Human Proteome
Alamar Biosciences (Alamar), a platform company focused on transforming the field of proteomics to enable the […]
Onxeo Appoints Julien Miara as New Interim CEO
Onxeo S.A. (Euronext Growth Paris: ALONX, Nasdaq First North: ONXEO), (“Onxeo” or “the Company”), a […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more